( December 12, 2024, 1:13 PM EST) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel declined “to second guess” a trial court’s factual findings in denying a preliminary injunction to Novartis Pharmaceuticals Corp. to halt the release of a generic version of the drug Entresto, finding that there was no “definite and firm conviction that a mistake” occurred....